# Self-management of type 2 diabetes using a co-designed text based mobile health (mHealth) intervention in Nepal: A study protocol for randomised controlled trial

**Authors:** Namuna Shrestha, Padam Simkhada, Om Kurmi, Shiva Gautam, Biraj Karmacharya, Akina Shrestha, Rajendra Tamrakar, Ak Narayan Poudel

PMC · DOI: 10.1371/journal.pone.0335333 · 2025-11-04

## TL;DR

This study will test a text-based mobile health program for managing type 2 diabetes in Nepal through a randomized trial.

## Contribution

The study introduces a co-designed mHealth intervention for diabetes self-management in the Nepalese context.

## Key findings

- The trial will assess changes in haemoglobin A1c levels after six months.
- Secondary outcomes include self-efficacy, perceived support, and quality of life.
- Data comparisons will use statistical tests for categorical and continuous variables.

## Abstract

Mobile health (mHealth) is increasingly being used for managing chronic diseases proving its feasibility, acceptability and effectiveness in improving the health outcomes. However, effectiveness of mHealth intervention for self-management of Type 2 diabetes remains unexplored in the context of Nepal. This study aims to develop and evaluate the effectiveness of a co-designed text based mobile health intervention for self-management of Type 2 diabetes in Nepal. We will conduct a six month, two arm (1:1) parallel group randomised control trial involving 154 adults with Type 2 diabetes. The primary outcome includes change in haemoglobin A1c level at six months follow up. Secondary outcomes include change in self-management outcomes such as self-efficacy, perceived support, diabetes related stress, health related quality of life and self-care activities. Primary and secondary outcomes will be summarized descriptively, and comparisons will be made using chi-square tests for categorical data and independent sample t-tests for continuous data. The trial is registered at ClinicalTrials.gov (NCT06623006).

## Linked entities

- **Diseases:** Type 2 diabetes (MONDO:0005148)

## Full-text entities

- **Diseases:** Type 2 diabetes (MESH:D003924), diabetes (MESH:D003920)
- **Chemicals:** A1c (-)

## Figures

4 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12585027/full.md

---
Source: https://tomesphere.com/paper/PMC12585027